Fundraising FoxLUMICKS
11 known investors
Find your way into LUMICKS
Sign up to see every warm intro you have to LUMICKS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LUMICKS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
Founders & leadership
Investors · 11
How we know: Lauxera Capital Partners's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$93M disclosed across 1 of 3 rounds · 2021–2024
- Undisclosed amountventure debtOct 2024Source ↗
- $93MSeries DApr 2021 · 2 sources
Farallon Capital Management (lead), Lauxera Capital Partners (lead), Gilde Healthcare, Irving Investors, Parian Global Management, Pura Vida Investments, Softbank Fund 2, Softbank Vision 2, T. Rowe Price Associates
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does LUMICKS do?
- LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
- Who founded LUMICKS?
- LUMICKS was founded by Andrea, Gerrit.
- Who are LUMICKS's investors?
- LUMICKS's investors include Lauxera Capital Partners, SoftBank Vision Fund, European Investment Bank, Gilde Healthcare, Irving Investors, Pura Vida Investments, T. Rowe Price.
- How much funding has LUMICKS raised?
- LUMICKS has disclosed $93M raised across 1 of its 3 known rounds.